A placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T (ID-KLH) and GM-CSF following rituximab in patients with CD20+ follicular lymphoma Meeting Abstract
| Authors: | Freedman, A. S.; Neelapu, S.; Nichols, C. R.; Robertson, M.; Djulbegovic, B.; Winter, J. N.; Gold, D.; Bender, J.; Stewart, M.; Ghalie, R. G.; Hamlin, P. A. |
| Abstract Title: | A placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T (ID-KLH) and GM-CSF following rituximab in patients with CD20+ follicular lymphoma |
| Meeting Title: | 50th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 112 |
| Issue: | 11 |
| Meeting Dates: | 2008 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2008-11-16 |
| Start Page: | 94 |
| Language: | English |
| ACCESSION: | WOS:000262104700237 |
| PROVIDER: | wos |
| PUBMED: | 22276298 |
| DOI: | 10.1182/blood.V112.11.236.236 |
| Notes: | --- - Meeting Abstract: 236 - Oral Session - 50th Annual Meeting of the American-Society-of-Hematology - DEC 06-09, 2008 - San Francisco, CA - "Source: Wos" |
